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Selective Activation and Expansion
of High-Affinity CD41 T Cells in Resistant Mice
upon Infection with Leishmania major
transfer of L. major–specific Th1 and Th2 cell lines to
naive hosts led to resistance or susceptibility, respec-
tively (Scott et al., 1990; Titus et al., 1991).
Although CD41 T cells play a critical role in determin-
ing the disease outcome, almost nothing is known about
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stimulated in vitro with SLA, or phorbol myristate acetate
(PMA) and ionomycin, and the frequency of cytokine-
secreting cells was assessed by intracellular stainingSummary
for IL-4 or IFN-g (Sommer et al., 1998). One week after
infection, a strong but comparable increase in the fre-Using multimers of MHC class II molecules linked to
quency of IFN-g- and IL-4-secreting CD41 T cells (upa peptide derived from the Leishmania LACK antigen,
to 7% of all CD41 cells) was observed in both C57BL/we have compared the fate of parasite-specific CD41
6 and BALB/c mice. Four weeks later, the frequency ofT cells in resistant and susceptible mice transgenic
IL-4-secreting cells had dropped to 1% in C57BL/6 micefor the b chain of a LACK-specific TCR. Activated T
but not in BALB/c animals.cells were readily detected in the draining lymph nodes
Although these studies have provided information onof infected animals. Although the kinetics of activation
the number of cytokine-secreting CD41 T cells in in-and expansion were similar in both strains, T cells
fected mice, measuring the actual frequency of parasite-from susceptible and resistant mice expressed low-
specific T cells was not possible due to the lack ofand high-affinity TCR, respectively. As T cells from
suitable reagents. Likewise, it has not been possible toresistant mice produced more IFN-g and less IL-4 than
monitor the surface phenotype of these cells during thethose from susceptible animals, our results suggest
course of the disease or to compare the kinetics of Tthat differences in TCR usage between MHC-matched
cell responses between resistant and susceptible ani-animals may influence the development of the antipar-
mals. To investigate these issues, we have producedasite immune response.
multivalent peptide/MHC molecules that bind selec-
tively to CD41 T cells reacting to the immunodominantIntroduction
Leishmania LACK antigen (Mougneau et al., 1995). We
have used these molecules as staining reagents to fol-In contrast to most inbred mouse strains that are resistant
low the fate of LACK-specific CD41 T cells in MHC-to infection with the intracellular parasite Leishmania ma-
matched resistant and susceptible mice upon infectionjor, BALB/c mice are unable to control infection and de-
with L. major.velop progressive lesions (Reiner and Locksley, 1995).
Several studies have shown that CD41 T cells are critical
Resultsin determining the outcome of the infection, while B cells
(Brown and Reiner, 1999) and CD81 T cells (Huber et
Protein A–Bound I-Ad/LACK Dimers Stainal., 1998) play only a minor role. Moreover, resistance
LACK-Specific CD41 T Cellsand susceptibility correlate with the development of
To visualize parasite-specific CD41 T cells, we madeTh1- and Th2-dominated responses, respectively. Thus,
dimers of soluble peptide/MHC molecules in which anwhile CD41 T cells from resistant mice secrete large
immunodominant peptide from the Leishmania LACKamounts of IFN-g and low levels of IL-4 and IL-5, those
antigen was covalently attached to the N-terminal endfrom susceptible animals produce mainly IL-4. The func-
of the class II I-Ad b chain. I-Ad a and b chains weretional importance of these different cytokine responses
truncated to eliminate their transmembrane regions andwas further demonstrated by experiments in which the
modified by the addition of leucine zipper peptide di-
mers at their COOH terminus as described (Scott et al.,
1996). The a chain was further modified by the addition§ To whom correspondence should be addressed (e-mail:
of the murine IgG2a Fc domain allowing for the produc-glaichenhaus@ipmc.cnrs.fr).
k These authors contributed equally to this work. tion of divalent molecules as previously described for a
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human MHC class II molecule (Appel et al., 2000). The
constructs were cloned into the vector pRMHa3 and
cotransfected into Drosophila S2 cells along with a neo-
mycin resistance gene to produce stable transfectants.
I-Ad/LACK divalent molecules were purified to homoge-
neity by affinity chromatography and subsequent ion
exchange chromatography.
We next investigated whether I-Ad/LACK dimers could
stain LACK-specific CD41 T cells. While flow cytometry
analysis did not show any binding of I-Ad/LACK dimers
to LACK-specific LMR8.2 hybridoma (data not shown),
stable and specific staining was achieved when I-Ad/
LACK dimers were preincubated with Alexa 488-cou-
pled protein A (Figure 1A). While both LACK-specific
LMR8.2 and HEL-specific B04H9.1 hybridomas were
stained with control anti-Cb mAbs, only LMR8.2 hybrid-
oma was stained with protein A–bound I-Ad/LACK di-
mers. In contrast, LMR8.2 hybridoma was not stained
with protein A–bound I-Ad molecules attached to a pep-
tide derived from the Leishmania GP63 protein. Specific
binding of I-Ad/LACK multimers to LACK-specific T cells
was independently demonstrated by staining thymo-
cytes from ABLE ab TCR transgenic mice that express
a LACK-specific TCR (Reiner et al., 1998). In these mice,
I-Ad/LACK multimers stained 70% of CD41CD82 thymo-
cytes as compared to only 0.2%–0.3% in wild-type (wt)
BALB/c mice (Figure 1B).
As an attempt to track LACK-specific T cells, we in-
jected BALB/c and B10.D2 wt mice with 2 3 106 L. major
promastigotes. Mice were sacrified at day 6, 10, and 21
days postinfection, and LN T cells were stained with
I-Ad/LACK multimers and anti-CD4 mAbs. No selective
expansion of I-Ad/LACK1 cells was observed in three
independent experiments (data not shown). This was
surprising, as infection with L. major was reported to
induce the expansion of a restricted population of CD41
cells that expressed Va8 and Vb4 (Reiner et al., 1993),
two TCR variable regions that are preferentially used by
LACK-specific T hybridomas. To rule out the possibility
Figure 1. Protein A–Bound I-Ad/LACK Dimers Stain LACK-Specificthat only a small proportion of LACK-specific T cells
T Cellswere stained by I-Ad/LACK multimers, we have immu-
(A) I-Ad/LACK multimer staining of T cell hybridomas. LACK-specificnized BALB/c mice with LACK, purified LN cells 6 days
LMR8.2 (left panel) and HEL-specific B04H9.1 (right panel) T celllater, and sorted I-Ad/LACK1 and I-Ad/LACK2 cells by
hybridomas were stained with protein A–bound I-Ad/LACK dimers
flow cytometry. In contrast to I-Ad/LACK1 cells, I-Ad/ (thick solid line), anti-Cb mAbs (thin solid line), or protein A–bound
LACK2 cells did not proliferate when incubated with I-Ad/GP63 dimers (dashed line). Data show representative FACS
analysis after gating on viable cells.LACK peptide and syngenic APCs (data not shown).
(B) I-Ad/LACK multimer staining of TCR transgenic thymocytes. Thymo-Thus, our inability to detect expansion of I-Ad/LACK1
cytes from ABLE TCR ab transgenic mice (left panel) and BALB/ccells in infected mice was not likely due to the sensitivity
wt mice (right panel) were stained with I-Ad/LACK multimers andof our staining procedure. In this respect, it is noteworthy
anti-CD4 and anti-CD8 mAbs. Plots display I-Ad/LACK multimer
that other investigators have failed to detect expansion staining after gating on CD41CD82 T cells. The percentage of I-Ad/
of Va81Vb41 T cells in infected BALB/c mice (Lohoff et LACK1 cells in the gated population is indicated.
(C and D) LN CD41 T cells from BALB/c 16.2b transgenic miceal., 1994; our unpublished data).
(left panels) and from their negative littermates (right panels) were
stained with anti-CD4 and (C) anti-Vb4 mAbs or (D) I-Ad/LACKFate of LACK-Specific T Cells in Mice Transgenic
multimers. Data show representative FACS analysis after gating on
for the b Chain of a LACK-Specific TCR CD41 viable cells. The percentage of (C) Vb41 and (D) I-Ad/LACK1
To facilitate the detection of LACK-specific T cells, we cells in the gated population is indicated.
constructed transgenic mice carrying the rearranged
TCR b chain gene of the LACK-specific LMR16.2 T cell
hybridoma (Mougneau et al., 1995). These mice, desig- in their negative littermates (Figure 1C). In addition, the
expression of the transgene resulted in an elevated fre-nated 16.2b, were crossed to BALB/c and B10.D2 mice
for 16 and 6 generations, respectively. In both transgenic quency of I-Ad/LACK1 cells (Figure 1D). As observed in
wt animals, the outcome of the disease was differentstrains, flow cytometry analysis showed that .96% of
CD41 T cells expressed Vb4 as compared to only 8.7% in BALB/c and B10.D2 transgenic animals. Thus, while
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Figure 2. Disease Progression and T Cell Re-
sponses in 16.2b Transgenic Mice
(A) BALB/c (open circles) and B10.D2 (filled
circles) 16.2b transgenic mice were injected
with 2 3 106 L. major promastigotes. The in-
crease in footpad thickness was measured
at the indicated times after infection. Bars
represent the arithmetic mean of six individ-
ual mice.
(B) Wt and 16.2b transgenic BALB/c and
B10.D2 mice were infected with L. major and
killed 4 weeks later. CD41 LN cells were puri-
fied and incubated with syngeneic APCs and
30 mg/ml of SLA. Supernatants were har-
vested 72 hr later and IL-2, IFN-g, IL-4, and
IL-5 contents were measured by ELISA. Data
show the results of a representative (out of
three) experiments.
BALB/c transgenic mice developed progressive footpad the expression of the TCR b transgene did not change
the tendency of B10.D2 and BALB/c mice to mount Th1-swelling, B10.D2 transgenic animals showed only tran-
sient lesions (Figure 2A). Likewise, when analyzed 3 and Th2-dominated responses, respectively. However,
transgenic T cells from BALB/c mice secreted less IL-4weeks after infection, the draining LN of BALB/c trans-
genic mice contained 100- to 1000-fold more parasites and IL-5 than those from their negative littermates, sug-
gesting that 16.2b transgenic animals had an impairedthan those from B10.D2 transgenic animals (data not
shown). Despite this latter result, 16.2b BALB/c trans- ability to mount a vigorous Th2 response.
To follow the kinetics of activation of LACK-specificgenic mice did not develop necrotic lesions, and para-
site loads in these mice reached a plateau 5 to 6 weeks T cells, 16.2b BALB/c mice were infected with 2 3 106
promastigotes, and CD41 cells from their draining LNafter infection.
To analyze parasite-specific cytokine responses, wt were stained with I-Ad/LACK multimers. Both the per-
centage and the absolute number of I-Ad/LACK1 cellsand 16.2b transgenic mice were infected with L. major.
Four weeks later, CD41 LN T cells were prepared and increased in the draining LN 1 day after infection and
peaked at day 3 (Figure 3A). At this time, the percentageincubated with syngeneic APCs and SLA. As expected,
CD41 T cells from B10.D2 wt mice secreted more IFN-g of I-Ad/LACK1 cells dropped but remained higher than
those found in uninfected animals up to 28 days afterand less IL-4 and IL-5 than those from BALB/c wt mice
(Figure 2B). Likewise, B10.D2 transgenic T cells secreted infection. While the absolute number of I-Ad/LACK1 cells
per LN also started to decrease after day 3, it increased15-fold more IFN-g, 3- to 4-fold less IL-2 and IL-4, and
8-fold less IL-5 than BALB/c transgenic T cells. Thus, again after day 14 (Figure 3B).
Immunity
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Figure 3. L. major Induces the Activation and
the Expansion of LACK-Specific T Cells in
BALB/c 16.2b Transgenic Mice
(A, B, C, D, and E) BALB/c and (A and B)
B10.D2 16.2b transgenic mice were infected
with 2 3 106 L. major promastigotes. At the
indicated times after infection, LN CD41 T
cells were purified and stained with (A, B, C,
D, and E) I-Ad/LACK multimers, anti-CD4 and
(C) anti-CD69 mAbs, or (D) anti-CD44 mAbs.
(A) The percentage and (B) absolute number
of I-Ad/LACK1 cells per LN in BALB/c (open
circles) and B10.D2 (filled circles) animals
were calculated after gating on CD41 viable
cells. Data show the arithmetic mean 6 SD
of five individual mice.
(C, D, and E) The percentage of I-Ad/LACK1
(filled bars) and I-Ad/LACK2 (empty bars) cells
expressing (C) CD69, (D) high levels for CD44,
or (E) exhibiting a large size was calculated
after gating on live CD41 T cells. Data show
the arithmetic mean of three individual mice.
(F) BALB/c 16.2b transgenic mice were given
BrdU in the drinking water at the time of the
infection and analyzed 3 days later. LN CD41
T cells were permeabilized and stained with
I-Ad/LACK multimers and anti-BrdU (thick
line) or control isotypic (thin line) mAbs. Rep-
resentative FACS analyses are shown after
gating on I-Ad/LACK1 (left panel) or I-Ad/
LACK2 (right panel) cells.
Infection with L. major induced I-Ad/LACK1 cells to demonstrate that the phenotype BALB/c I-Ad/LACK1
transgenic cells rapidly changed in response to L. majorundergo rapid phenotypic changes. Indeed, in contrast
to I-Ad/LACK2 cells that did not exhibit apparent surface and that these cells accumulated in the draining LN as
the result of parasite-induced proliferation.phenotypic changes during the course of the infection,
the frequency of I-Ad/LACK1 cells expressing CD69 in-
creased from 15%–20% at day 0 to 65% and 80% at BALB/c and B10.D2 Transgenic T Cells Exhibit
the Same Kinetics of Activation and Expansionday 1 and 2, respectively (Figure 3C). Likewise, the fre-
quency of CD44high I-Ad/LACK1 cells increased from 10% but Secrete Different Cytokines
To compare the kinetics of T cell expansion in B10.D2at day 0 to 78% at day 2 and remained constant up to
4 days after infection (Figure 3D). To determine whether and BALB/c mice, transgenic mice from these two
strains were injected with L. major and cells from theirL. major induced I-Ad/LACK1 T cells to progress through
the cell cycle, 16.2b mice were given BrdU in their drink- draining LN were analyzed at different times after infec-
tion. As observed in BALB/c mice, the frequency of I-Ad/ing water at day 0, and LN cells were analyzed 3 days
later for BrdU incorporation. The proportion of BrdU1 LACK1 B10.D2 transgenic T cells peaked to 8%–10%
at day 3 and dropped to 2%–2.5% 4 weeks later (Figurecells among I-Ad/LACK1 and I-Ad/LACK2 cells was 60%
and 10.3%, respectively (Figure 3F). Similarly, the fre- 3A). Although B10.D2 mice exhibited less CD41 T cells
per LN than BALB/c mice, the absolute number of I-Ad/quency of large I-Ad/LACK1 cells rapidly increased in
infected mice as assessed by FSC analysis (Figure 3E). LACK1 cells per LN increased in both strains peaking 3
days after infection, dropping thereafter, and increasingThus, in contrast to the frequency of large I-Ad/LACK2
cells that remained constant through the infection, the again after day 14 (Figure 3B).
We next analyzed the surface phenotype of I-Ad/frequency of large I-Ad/LACK1 cells increased from
3%–5% at day 0 to almost 80% at day 2 and eventually LACK1 cells from BALB/c and B10.D2 16.2b transgenic
mice 3 weeks after infection. CD41 LN cells were pre-dropped to 40% at day 4. Taken together, these results
Parasite-Specific CD41 T Cells in Leishmaniasis
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Figure 4. Surface Phenotype and Cytokine Secretion Profiles of LACK-Specific T Cells in BALB/c and B10.D2 16.2b Transgenic Mice
Mice were infected or not with 2 3 106 L. major promastigotes, and CD41 LN T cells were prepared 3 weeks later.
(A) Cells were stained with I-Ad/LACK multimers, anti-CD44 and anti-CD69 mAbs. Data show representative FACS profiles of cells from
uninfected (left panel) or infected (right panels) mice. The percentages of CD44high, CD691, and CD44highCD691 cells are indicated after gating
on the indicated population.
(B) Cells were incubated with syngeneic APCs and 10 mM of LACK peptide. Supernatants were harvested 72 hr later and IL-2, IFN-g, IL-4,
and IL-5 contents were measured by ELISA. Data show the amount of cytokine normalized to 103 I-Ad/LACK1 cells. Data show the results of
a representative (out of three) experiments.
pared and stained with I-Ad/LACK multimers and anti- the same kinetics of activation and expansion, they did
not secrete the same cytokines.CD44 and anti-CD69 mAbs. In both strains, the surface
phenotype of I-Ad/LACK2 cells did not change during
the course of the infection. In striking contrast, the pro- BALB/c and B10.D2 Transgenic T Cells Express
portion of CD44high I-Ad/LACK1 cells in BALB/c and Low- and High-Affinity TCR, Respectively
B10.D2 animals increased from 10%–15% at day 0 to During the course of these studies, we noticed that I-Ad/
40%–50% at day 22 (Figure 4A). Similarly, the proportion LACK1 cells from B10.D2 transgenic mice stained more
of I-Ad/LACK1 cells expressing CD69 increased from brightly with I-Ad/LACK multimers than those from
8%–10% before infection to 30%–40% 3 weeks later BALB/c animals. This phenomenon was observed as
(Figure 4A). At that time, 16% and 27% of I-Ad/LACK1 early as day 3 after infection, but not at day 0, 1, or 2
cells expressed both CD69 and high levels of CD44 in (Figure 5A). Differences in staining profiles could result
B10.D2 and BALB/c mice, respectively. from differences in the level of TCR expression or in
To compare the ability of BALB/c and B10.D2 LACK- the affinity of the TCR for their common peptide/MHC
specific T cells to secrete cytokines, CD41 LN cells were ligand. Indeed, previous studies have demonstrated that
purified from infected mice 4 weeks after infection and there is a direct correlation between the extent of pep-
incubated with syngeneic APCs and LACK peptide. After tide/MHC multimer binding and receptor affinity (Craw-
normalizing for each sample, the amount of cytokine to ford et al., 1998; Savage et al., 1999).
the number of I-Ad/LACK1 T cells, we found that trans- To address this issue, we have used the previously
genic T cells from B10.D2 mice secreted 12- to 15-fold described multimer dissociation assay to compare the
more IFN-g, 3-fold less IL-2 and IL-4, and 2-fold less half-lives of I-Ad/LACK multimer binding to BALB/c and
IL-5 than those from BALB/c animals (Figure 4B). Thus, B10.D2 LACK-specific transgenic T cells (Savage et al.,
1999). CD41 LN cells were purified from mice 3 dayswhile BALB/c and B10.D2 transgenic T cells exhibited
Immunity
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Figure 5. B10.D2 and BALB/c Transgenic T Cells Express TCR of Different Affinity
16.2b transgenic mice were infected with 2 3 106 L. major promastigotes. At the indicated times after infection (A) or 3 days after infection
(B, C, and D), LN CD41 T cells were stained with I-Ad/LACK multimers and anti-CD4.
(A) Representative FACS analysis of BALB/c (thin line) and B10.D2 (thick line) transgenic T cells after gating on I-Ad/LACK1 CD41 viable cells.
(B) Multimer staining decay kinetics for BALB/c and B10.D2 I-Ad/LACK1 cells stained with I-Ad/LACK multimer. The natural logarithm of the
normalized fluorescence is plotted versus time after the addition of M5/114 mAbs. Multimer staining was measured at 0, 5, 10, 15, 20, and
25 min after M5/114 addition. Data show I-Ad/LACK multimer dissociation from B10.D2 (filled circles) and BALB/c (open circles) I-Ad/LACK1
cells, respectively.
(C) Scatchard analysis of I-Ad/LACK multimer binding to I-Ad/LACK1 T cells. BALB/c (open circles) and B10.D2 (filled circles) cells were stained
with I-Ad/LACK multimer over a range of concentrations. Apparent KD values were derived from Scatchard plots of bound multimer/free
multimer versus bound multimer.
(D) Immunoscope analysis of CDR3a regions. I-Ad/LACK1 and I-Ad/LACK2 CD41 LN cells from 16.2b BALB/c (upper panel) and B10.D2 (lower
panel) mice were sorted by flow cytometry. cDNA were amplified by PCR using AC and the indicated AV-specific primers followed by a run-
off with a nested fluorescent AC-specific primer. The run-off products were size fractionated in an automated DNA sequencer, and the CDR3
size distribution was analyzed using the Immunoscope software.
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after infection and stained with I-Ad/LACK multimers at I-Ad/LACK2 cells showed a Gaussian-like distribution of
the peaks (Figure 5D).48C. After washing, the rate of staining decay was mea-
sured by flow cytometry in the presence of saturating
amounts of the M5/114 monoclonal antibody. While I-Ad/ A Possible Link between T Cell Repertoire
LACK multimers label on B10.D2 LACK-specific T cells Selection and Cytokine Secretion
decayed with a t1/2 of 162 6 32 min, I-Ad/LACK multimers To get further insights into a possible relationship between
label on BALB/c LACK-specific T cells decayed with a T cell repertoire and cytokine secretion, (BALB/c 3
t1/2 of 43 6 7 min (Figure 5B). To determine apparent B10.D2) F1 16.2b transgenic mice were generated and
KD values for multimer binding to BALB/c and B10.D2 intercrossed to obtain F2 transgenic mice. These F2
LACK-specific T cells, multimer binding to these cells mice and sex-matched BALB/c and B10.D2 control
was evaluated under equilibrium staining conditions as transgenic animals were infected with L. major and killed
described (Savage et al., 1999). While I-Ad/LACK 3 weeks later. CD41 LN T cells from individual mice
multimer binding to B10.D2 trangenic T cells exhibited were prepared and analyzed for cytokine production
an apparent KD of 19.5 6 0.5 nM, the apparent KD value following in vitro stimulation with LACK peptide. In paral-
for binding to BALB/c trangenic T cells was 46 6 4 nM lel, the apparent KD values for multimer binding to I-Ad/
(Figure 5C). LACK1 cells were measured under equilibrium staining
To independently confirm that BALB/c and B10.D2 conditions at 48C. As previously observed for mice ana-
LACK-specific T cells expressed low- and high-affinity lyzed 3 days after infection, the apparent KD values for
TCR, respectively, we generated hybridomas from the multimer binding to BALB/c T cells were higher than
LN of BALB/c and B10.D2 infected transgenic mice. those measured for B10.D2 T cells (22.0 6 1.1 nM versus
These hybridomas were stained separately with I-Ad/LACK 8.9 6 1.7 nM) (Figure 6). In addition, BALB/c T cells
multimers and anti-Vb4 mAbs to normalize the mean fluo- secreted less IFN-g and more IL-4 (measured as a lower
rescence intensity (MFI) obtained after multimer binding IFN-g/IL-4 ratio) than B10.D2 T cells. Among 26 F2 mice,
to the level of TCR surface expression. While seven out 24 exhibited relatively low apparent KD values (ranging
of eight BALB/c hybridomas exhibited a normalized MFI from 6 to 15 nM) and relatively high IFN-g/IL-4 ratio.
ranging from 0.2 to 0.68, all B10.D2 hybridomas exhib- Interestingly, the only two mice that exhibited high ap-
ited MFI ranging from 1.2 to 1.7 (Table 1). In agreement parent KD values (29.0 nM and 31.0 nM) were also char-
with this latter result, the apparent KD value for multimer acterized by a low IFN-g/IL-4 ratio.
binding to the BALB/c LMR4.1 and LMR4.2 hybridomas
were higher than those measured for the B10.D2 LMR7.5 Discussion
and LMR8.4 hybridomas (53 and 21.5 nM versus 11.9
and 7.5 nM) (Table 1). The use of peptide/MHC tetramers to stain T cells has
If BALB/c and B10.D2 transgenic T cells express TCR revolutionized our appreciation of the numerology of the
of different affinity, they should use different a chains. CD81 T cell response to bacterial or viral infections.
To confirm this, the TCR a chains expressed by our Here, we have used a similar approach to follow the fate
panel of LACK-specific hybridomas were analyzed by of parasite-specific CD41 T cells in mice infected with
RT-PCR and sequenced. While six different Va regions L. major. To this aim, we made molecular probes in
were found in the eight BALB/c-derived hybridomas, which a peptide derived from the immunodominant
three out of three B10.D2-derived hybridomas used the LACK antigen was linked to MHC class II I-Ad molecules.
same AV3-J25 rearrangement with a conserved 10 Dimers of I-Ad/LACK molecules were produced in Dro-
amino acid CDR3 loop (Table 1). Because of a possible sophila cells and incubated with fluorochrome-conju-
bias in hybridoma sampling, we used flow cytometry to gated protein A. Protein A–bound I-Ad/LACK dimers
purify I-Ad/LACK1 and I-Ad/LACK2 cells from L. major– stained LACK-specific hybridoma and CD41 T cells from
infected transgenic animals. We then analyzed the CDR3 TCR transgenic mice that carried the rearranged TCR
size distribution of TCR a chains in the sorted popula- a and b chain gene of a LACK-specific hybridoma. Our
tions using six different AV- and AC-specific primers approach to make peptide/MHC multimers was different
and the Immunoscope technique (Pannetier et al., 1993) from the standard strategy in which peptide/MHC mono-
(Figure 5D). For five out of the six rearrangements ana- mers were biotinylated and eventually obtained as
lyzed (AV3, AV4, AV5, AV6, and AV10), the CDR3 size fluorescent tetramers following incubation with fluoro-
pattern distribution was different between BALB/c and chrome-conjugated streptavidin. Although streptavidin-
B10.D2 transgenic T cells. This was striking for AV3-AC bound tetramers are now routinely used to stain antigen-
and AV6-AV elongation products where a unique CDR3 specific CD81 T cells, only a few investigators have
peak was observed in B10.D2, but not in BALB/c mice. successfully used it to stain CD41 T cells (McMichael
After sequencing, only AV3-AC PCR products gave a and Kelleher, 1999). Our strategy does not require pep-
readable sequence that was identical to the CDR3 region tide/MHC molecules to be biotinylated in vitro, a proce-
of the LMR7.5 and LMR8.1 hybridomas (Table 1). In dure that can be technically difficult. Although we have
contrast, Immunoscope analysis of rearranged TCR not systematically compared our strategy with others,
bearing the AV8 gene segment revealed a single peak all protein A–bound MHC/peptide dimers that we have
in both BALB/c and B10.D2 mice. In both strains, direct made so far were biologically active, including those in
sequencing of the AV8-AC PCR products gave a read- which antigenic peptides were bound to the unstable
able AV8-AJ8 sequence that was identical to the se- NOD I-Ag7 molecules (our unpublished data).
quence found in the LMR4.11 hybridoma. As a control, To facilitate the detection of LACK-specific T cells,
we have constructed a transgenic mouse strain, 16.2b,the analysis of the AV8-C rearrangements performed on
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trast, although the number of I-Ad/LACK2 cells increased
in the draining LN as the result of the infection, these
cells did not progress through the cell cycle and their
surface phenotype did not change over time, arguing
against L. major–induced activation of bystander T cells.
Altogether, our results suggest that the increase in the
number of LN CD41 T cells induced by L. major resulted
both from the nonspecific recruitment of cells to the
draining LN and from the antigen-driven proliferation of
parasite-specific T cells within this lymphoid organ.
At any time after infection, the number of antigen-
specific T cells in the draining LN reflects the rates at
which T cells proliferate, die, or migrate to other organs.
Because of this dynamic process, it is difficult to draw
conclusions from variations in the number of antigen-
specific cells during the course of the disease. Neverthe-
less, it is striking that both the frequency and the abso-
Figure 6. Apparent KD Values and Cytokine Secretion Profiles of T lute numbers of LACK-specific T cells in the draining
Cells from (B10.D10 3 BALB/c) F2 Transgenic Mice LN dropped 3 days after infection. At that time, the
BALB/c (open circles), B10.D2 (gray squares), and (B10.D10 3 proportion of cells expressing CD69 and/or progressing
BALB/c) F2 (filled triangles) 16.2b transgenic mice were infected through the cell cycle also started to decrease, a result
with L. major, and LN CD41 cells were purified 3 weeks later. The that could be explained by the transient disappearance
apparent KD value for multimer binding to I-Ad/LACK1 cells was of DCs as the result of their killing by activated T cellsdetermined for individual mice as described in the legend to Figure
(Ingulli et al., 1997). At later times, the frequency of5. LN cells were stimulated with LACK for 72 hr, and cellular superna-
LACK-specific T cells in the LN of both resistant andtants were analyzed for IL-4 and IFN-g content by ELISA. For each
mouse, data show the apparent KD value versus the ratio between susceptible mice reached a plateau, but the absolute
IFN-g and IL-4 production. numbers of these cells increased again. Three weeks
after infection, a relatively high proportion of LACK-spe-
cific T cells expressed CD69, suggesting that antigen-which carried the rearranged b gene of a LACK-specific
dependent stimulation was still taking place. Thus, inTCR and exhibited an increased frequency of LACK-
the late stages of the disease, parasite-specific T cellsspecific T cells. As observed wt animals, 16.2b trans-
were continuously activated but their frequency in thegenic mice that have been crossed to BALB/c mice
draining LN did not increase, possibly because of ho-developed larger lesions and exhibited higher parasite
meostatic mechanisms. Chronic stimulation of parasite-loads than those crossed to B10.D2 mice. In agreement
specific T cells was not unexpected in BALB/c mice aswith a critical role of Th1 cells in resistance to infection,
they exhibited high parasite loads. However, although
B10.D2 transgenic T cells secreted more IFN-g and less
L. major amastigotes have been demonstrated to persist
IL-4 and IL-5 when incubated with SLA than BALB/c
in resistant mice for more than 1 year, it was unclear
transgenic T cells. However, while both BALB/c and
whether chronic infection was associated with persis-
B10.D2 transgenic T cells secreted more IFN-g than tent activation of parasite-specific T cells (Aebischer et
those from their negative littermates, they secreted less al., 1993). Our results suggest that this is indeed the
IL-4 and IL-5, suggesting that 16.2b transgenic mice case.
were impaired in their ability to mount a strong Th2 Using I-Ad/LACK multimers, we found that infection
response. At least two hypotheses could account for with as little as 2 3 106 promastigotes caused a dramatic
this latter result. First, the TCR b transgene used to expansion of LACK-specific T cells in 16.2b transgenic
generate 16.2b mice was derived from a Th1 clone, and mice. As L. major promastigotes express 230,000 LACK
it could be that T cells expressing this particular b chain molecules per cell (Fowell and Locksley, 1999), maximal
may have a predisposition to differentiate into IFN-g- expansion of LACK-specific T cells was observed with
secreting cells. Alternatively, the efficient allelic exclu- less than 2 3 10211 moles of LACK antigen, i.e., 1000-
sion resulting from the expression of the TCR b trans- fold fewer molecules than needed to activate T cells in
gene may have prevented the development of regulatory BALB/c mice adoptively transferred with OVA-specific
T cells required for a vigorous Th2 response. T cells and immunized with OVA (Kearney et al., 1994).
Using I-Ad/LACK multimers as staining reagents, we Epidermal Langerhans cells (LC) can internalize L. major
found that LACK-specific T cells rapidly expanded in amastigotes and transport them from the skin to the
the draining LN of infected transgenic mice. Selective draining LN (Moll et al., 1993). In addition, parasite inter-
expansion was readily detectable 1 day after infection nalization by LC-like dendritic cells induces these cells
and peaked 2 days later. At that time, the number of to upregulate MHC class I and II surface antigens, to
I-Ad/LACK1 cells per LN increased by 50- to 100-fold, express high levels of costimulatory molecules (CD40,
mainly as the result of antigen-driven proliferation. L. CD54, CD80, and CD86), and to release IL-12 p40 (von
major also induced LACK-specific T cells to rapidly ex- Stebut et al., 1998). Thus, the ability of L. major promasti-
press CD69 and to upregulate CD44, a phenomenon gotes to induce the activation and the expansion of
that was previously observed in mice immunized with parasite-specific T cells may result from their ability to
cytochrome C (McHeyzer-Williams and Davis, 1995) or be captured by DCs and to induce their differentiation.
While the kinetics of expansion and contraction ofovalbumin (OVA) (Kearney et al., 1994). In striking con-
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LACK-specific T cells were similar in BALB/c and B10.D2 two that exhibited relatively high apparent KD values
and relatively low IFN-g/IL-4 ratios, developed smallertransgenic mice, B10.D2 T cells stained more brightly
with I-Ad/LACK multimers than BALB/c T cells. Differ- lesions than control BALB/c mice. Previous studies have
demonstrated the complexity of the mechanisms thatences in I-Ad/LACK multimer staining were associated
with strain-specific differences in AV gene usage. In lead to resistance (Shankar and Titus, 1995; Beebe et
al., 1997; Roberts et al., 1997). Thus, both T cell andBALB/c mice, the TCR AV repertoire was quite diverse,
with T cells using different AV gene segments with CDR3 non–T cell compartments were shown to independently
determine resistance to Leishmania major (Shankar andloops of variable size. In contrast, the TCR AV repertoire
in B10.D2 mice was characterized by the preferential Titus, 1995). Furthermore, genetic experiments have
shown that resistance is under the control of at leastexpansion of T cells expressing the AV3-J25 rearrange-
ment with a conserved 10 amino acids long CDR3 motif. six genetic loci. The presence of all loci was not neces-
sary to confer resistance and no single locus was re-Further experiments showed that the apparent KD values
for multimer binding to BALB/c T cells were higher than quired. Rather, a variety of combinations of these loci
were capable of interacting to confer resistance (Beebethose measured for B10.D2 T cells. Likewise, I-Ad/LACK
multimers dissociated more rapidly from BALB/c than et al., 1997). Together with these previous studies, our
data suggest that mice may be able to control the infec-from B10.D2 T cells. Thus, while I-Ad/LACK1 T cells from
infected BALB/c mice expressed a diverse repertoire tion despite developing a Th2-biased immune response.
Thus, while the expansion of high-affinity T cells andand low-affinity TCR, those from B10.D2 animals ex-
pressed a restricted repertoire and high-affinity TCR. the subsequent development of Th1 cells may be suffi-
cient to confer resistance, it may not be necessary.What are the reasons for this phenomenon? Although
we cannot rule out that the preimmune repertoires of In earlier studies, Bretsher et al. (1992) have infected
BALB/c mice with various numbers of L. major promasti-BALB/c and B10.D2 16.2b transgenic mice were differ-
ent, our preliminary data suggest that this is not the gotes. While mice infected with high numbers of para-
sites developed progressive lesions and mounted a Th2-case. By analyzing the CDR3 size distribution among
rearranged TCR AV3, AV6, and AV8 gene segments on dominated response, those infected with low numbers
developed a protective Th1-polarized T cell response.CD41 T cells from naive BALB/c and B10.D2 transgenic
mice, we could not find any significant bias in CDR3 More recently, Rees et al. (1999) have demonstrated
that there was an inverse relationship between T celllength between these two strains. Thus, the absence of
high-affinity T cells in the LN of infected BALB/c trans- receptor affinity and antigen dose during CD41 T cell
responses in vivo. Our data provide a link between thesegenic mice was likely to result from an impaired ability
of these mice to select high-affinity T cells during the two studies by suggesting that infection of BALB/c mice
with low number of promastigotes could favor the selec-course of the infection. This phenomenon may be re-
lated to strain-specific T cell–intrinsic differences (Guler tive expansion of high-affinity T cells that may eventually
differentiate along the Th1 pathway.et al., 1996; Bix et al., 1998) or to differences in the non-
T cell compartment (Scott, 1991; Laskay et al., 1995).
Experimental ProceduresIt may be of interest that BALB/c and B10.D2 trans-
genic T cells expressed TCR of different affinities and
Mice and Parasites
secreted different amounts of IL-4 and IFN-g. Although BALB/c and B10.D2 mice were purchased from Harlan, UK. All mice
it remains to be established whether there is a causal were used between 8 and 12 weeks of age. Mice were bred and
relationship between TCR affinity and phenotype acqui- housed under specific pathogen-free conditions. ABLE TCR ab
transgenic mice have been described (Reiner et al., 1998). 16.2bsition, many studies have suggested that the strength
transgenic mice were produced by microinjection of the rearrangedof signal through the TCR may influence the generation
TCR b chain gene of the LACK-specific LMR16.2 T cell hybridomaof Th1 and Th2 effector lymphocytes in vivo (Pfeiffer et
(Mougneau et al., 1995) into (B10.S 3 C57BL/6) F1 fertilized eggs and
al., 1995) and in vitro (Constant et al., 1995; Hosken et implantation into pseudopregnant foster mothers. One transgene
al., 1995). As a first attempt to address this issue, we positive founder was identified by Southern analysis of tail DNA,
have generated F2 transgenic mice by intercrossing F1 and crossed to BALB/c and B10.D2 for 15 and 5 generations, re-
spectively. Offspring were monitored for expression of the TCR b(BALB/c 3 B10.D2) 16.2b mice. When mice were ana-
transgene by flow cytometry of peripheral blood cells using KT4.1lyzed 3 weeks after infection, 24 out of 26 F2 mice exhib-
anti-Vb4 mAbs. For infection, L. major (World Health Organizationited apparent KD values for multimer binding to I-Ad/ strain WHOM/IR/-/173) promastigotes were grown in M199 con-
LACK1 cells that were in the same range as those ob- taining 20% FCS and used as described (Mougneau et al., 1995).
served for B10.D2 animals. These 24 F2 mice also exhib-
ited Th1-polarized immune responses similar to those Reagents and Antibodies
LACK peptide (aa 158 through 173; FSPSLEHPIVVSGSWD) was pur-observed in B10.D2 animals. In striking contrast, two F2
chased from Mimotopes (Suresnes, France). BrdU was purchasedmice exhibited relatively high apparent KD values and
from Sigma SARL (St. Quentin Fallavier, France). SLA was preparedmounted Th2-dominated responses comparable to
as described (Scott et al., 1990). The following mAbs were used for
those developed by BALB/c transgenic mice. Although stimulation, cell purification, or flow cytometry analysis: GK1.5, anti-
we cannot rule out that repertoire selection and cytokine CD4; 53-6.7, anti-CD8a; KT4.1, anti-Vb4; H57-597, anti-Cb; H1.2F3,
anti-CD69; IM7, anti-CD44; M1/70, anti-CD11b; RA3-6B2, anti-B220;secretion were governed by different genes that would
2G9, anti-I-Ad/I-Ed ; and 3D4, anti-BrdU. All mAbs were purchasedhave segregated together in these two F2 mice, our
from Becton Dickinson SA (Le Pont de Claix, France).results strongly suggest that whatever determines T cell
differentiation also governs the LACK-specific TCR rep-
Production of Soluble I-Ad/LACK Dimers and Multimeric
ertoire. Staining Reagents
Although we have not measured parasite loads in F2 Constructs encoding the extracellular domains of I-Ad a and b chains
fused to acidic/basic leucine zipper sequences (Scott et al., 1996)mice, it is striking that all these animals, including the
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were modified as followed. The a chain construct was modified by Staining decay assays and scatchard analysis were performed
as described (Savage et al., 1999) with the difference that cells werethe addition of a sequence encoding the Fc region of murine IgG2a
antibodies. For the b chain construct, a sequence coding for either stained for 1 hr on ice. For staining decay assays, cells were stained
with I-Ad/LACK multimers, washed three times, and resuspended ina LACK-derived peptide (amino acids 156 through 173) (FSPSLEH
PIVVSGSW) or a GP63-derived peptide (amino acids 364 through 100 ml BSA-containing PBS and 100 mg/ml of M5/114 anti-I-Ad mAbs.
378) (GSCTQRASEAHASLL) was covalently attached by a six-resi-
due linker and a thrombin cleavage site to the amino terminus of T Cell Repertoire Analysis
the I-Ad b chain as described (Kozono et al., 1994). Recombinant RNA was extracted from T cell hybridomas or from sorted cell popu-
cDNA were cloned into the pRMHa3 expression vector and trans- lations, and cDNA was synthesized as described (Pannetier et al.,
fected into Drosophila S2 cells, and stable transfectants were se- 1993). To analyze Va chain usage by LACK-specific hybridomas,
lected as described (Scott et al., 1996). For large scale culture, PCR was performed on cDNA using a set of 19 AV segment-specific
transfectants were grown at 248C in SFM medium (Life Technology primers and analyzed on a 2% agarose gel stained with ethidium
SARL, Cergy Pontoise, France) supplemented with 1% FCS. When bromide. AV-ACa PCR product (5 ml) was incubated for 40 min
the cell density reached 5 3 106 cells/ml, expression was induced at 378C with 0.5 U of Shrimp Alkaline Phosphatase and 10 U of
by addition of copper sulfate (0.5 mM). Supernatants were harvested Exonuclease I (Amersham Pharmacia Biotech Europe GbmH) in 10
5 days later and concentrated using a Prepscale Concentrator (Milli- ml. Sequencing reactions were performed using ACb internal primer
pore S.A., St. Quentin Yvelines, France). I-Ad/LACK dimers were and the ABI PRISM Dye Terminator Cycle Sequencing Ready Reac-
purified from supernatants by affinity chromatography using MK- tion Kit (Perkin Elmer Biosystems, Foster City). Sequences were run
D6 mAbs. Bound molecules were eluted by CAPS 50 mM (pH 11.5), on a 373A DNA sequencer (Perkin Elmer Biosystems). Immunoscope
and the collected fractions were neutralized with 200 mM sodium analysis was performed as described (Pannetier et al., 1993) using
phosphate (pH 6.2). Fractions containing I-Ad/peptide dimers were AV- and AC-specific (Casanova et al., 1991).
identified by SDS/PAGE (10%), pooled, and I-Ad/peptide dimers
were further purified by anion exchange HPLC using a MonoQ Acknowledgments
HR5/5 column (Amersham Phamarcia Biotech Europe GmbH,
Saclay, France). The column was equilibrated with 20 mM Tris (pH This work was supported by grants from the Ministe`re de l’Education
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